Oaktree Acquisition III Life Sciences Free Cash Flow 2025-2024 | OACC

Oaktree Acquisition III Life Sciences free cash flow from 2025 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.

Oaktree Acquisition III Life Sciences Free Cash Flow 2025-2024 | OACC

Oaktree Acquisition III Life Sciences free cash flow from 2025 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Related Stocks
Company NameMarket
Cap
Millrose Properties (MRP)$3.8B
PicoCELA (PCLA)$190M
Aduro Clean Technologies (ADUR)$167M
Range Capital Acquisition (RANG)$140M
Tavia Acquisition (TAVI)$139M
CO2 Energy Transition (NOEM)$94M
Leishen Energy Holding (LSE)$89M
YHN Acquisition I (YHNA)$81M
Youxin Technology (YAAS)$60M
YSX Tech (YSXT)$54M
New Century Logistics (BVI) (NCEW)$29M
Hong Kong Pharma Digital Technology Holdings (HKPD)$22M
Sky Quarry (SKYQ)$17M
Karman Holdings (KRMN)$0M
Aardvark Therapeutics (AARD)$0M
Northpointe Bancshares (NPB)$0M
Flowco Holdings (FLOC)$0M
FG Merger II (FGMC)$0M
SailPoint (SAIL)$0M
Aureus Greenway Holdings (AGH)$0M